Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Convergence Chemicals was an Indian specialty fluorochemicals manufacturing company that supplied starting materials used in Piramal Pharma's anesthetics business. Incorporated in 2014, the company operated as a private subsidiary/joint venture structure involving Piramal Pharma and Navin Fluorine before Piramal increased its ownership to 100% in 2020. The business was not a drug developer and did not appear to run a therapeutic pipeline; instead, it focused on manufacturing specialty fluorochemical intermediates for pharmaceutical production. In 2022, Convergence Chemicals was amalgamated into Piramal Pharma Limited as part of a composite scheme of arrangement. The entity therefore appears to be a former operating company rather than a currently standalone active business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Convergence Chemical.